| 3/20/2024 | 30049099 | Dato-DXd medicine (DS-1062a) 100mg Dato-DXd lyophilized powder for mixing intravenous infusion solution, box of 1 vial. Lot 36195.1/1. Deadline May 31, 2026. Manufacturer Baxter Oncology GmbH. 100% New | XXXXXXXXXX | 23 | UNK | 2029.7684 | Germany | NA |
| 3/20/2024 | 30049099 | Dato-DXd medicine (DS-1062a) 100mg Dato-DXd lyophilized powder for mixing intravenous infusion solution, box of 1 vial. Lot 36195.1/1. Deadline May 31, 2026. Manufacturer Baxter Oncology GmbH. 100% New | XXXXXXXXXX | 23 | UNK | 2029.7684 | Germany | NA |
| 3/13/2024 | 30049099 | New drug Cetrotide (Cetrorelix (as cetrorelix acetate) 0.25 mg).Powder for solution for injection.Batch:3I162D,3I162E.3I162F.SX:14.09.2023.HD:13.09.2025. Registration number:VN-16831-13.CSSX of powder vials:Baxter Oncology GmbH. | XXXXXXXXXX | 1431 | UNK | 220153.626 | Germany | NA |
| 3/13/2024 | 30049099 | Enfortumab Vedotin-ejfv powder for solution for injection, box of 1 vial of 20mg. Lot number 72797.19/1. Expiry date May 31, 2024. Manufacturer: Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 24 | UNK | 61781.76 | Germany | NA |
| 3/13/2024 | 30049099 | New drug Cetrotide (Cetrorelix (as cetrorelix acetate) 0.25 mg). Powder for solution for injection. Batch:3I162G. Production: September 14, 2023. HD:September 13, 2025. Registration number: VN-16831-13. Manufacturer of powder vials: Baxter Oncology GmbH. | XXXXXXXXXX | 835 | UNK | 128461.41 | Germany | NA |
| 3/13/2024 | 30049099 | New drug Cetrotide (Cetrorelix (as cetrorelix acetate) 0.25 mg). Powder for solution for injection. Batch:3I163A. Production: September 22, 2023. HD: September 21, 2025. Registration number: VN-16831-13. Manufacturer of powder vials: Baxter Oncology GmbH. | XXXXXXXXXX | 635 | UNK | 97692.21 | Germany | NA |
| 2/26/2024 | 30049099 | New drug Cetrotide (Cetrorelix (as cetrorelix acetate) 0.25 mg). Powder for solution for injection. Batch:3I162D. Production: September 14, 2023. HD:September 13, 2025. Registration number: VN-16831-13. Manufacturer of powder vials: Baxter Oncology GmbH. | XXXXXXXXXX | 919 | UNK | 142021.2491 | Germany | NA |
| 2/26/2024 | 30049099 | New drug Cetrotide (Cetrorelix (as cetrorelix acetate) 0.25 mg). Powder for solution for injection. Batch:3I162C. Production: September 14, 2023. HD:September 13, 2025. Registration number: VN-16831-13. Manufacturer of powder vials: Baxter Oncology GmbH. | XXXXXXXXXX | 1081 | UNK | 167056.5509 | Germany | NA |
| 1/23/2024 | 30049099 | Enfortumab Vedotin-ejfv powder for solution for injection, box of 1 vial of 20mg. Lot number 72797.19/1. Expiry date May 31, 2024. Manufacturer: Baxter Oncology GmbH. New 100% | XXXXXXXXXX | 25 | Box/Bag/Pack | 64738.5605 | Germany | NA |
| 1/22/2024 | 30049099 | New drug Cetrotide (Cetrorelix (as cetrorelix acetate) 0.25 mg). Powder for solution for injection. Batch:3H160D. Production: August 18, 2023. HD:August 17, 2025. Registration number: VN-16831-13. Manufacturer of powder vials: Baxter Oncology GmbH. | XXXXXXXXXX | 2458 | Box/Bag/Pack | 380401.9235 | Germany | NA |